Preoperative Immunotherapy Triggers Encouraging Response in Oral Cancers
Immunotherapy given before other treatments for oral cavity cancers may elicit an immune response that shrinks tumors, which could provide long-term benefits for.
Industry News
Industry News
Immunotherapy Improves Survival Rates of Advanced Head and Neck Cancer Patients
A new immunotherapy drug known as nivolumab greatly improves survival for patients with relapsed head and neck cancer, as more than twice as.
